Abstract. Ligation of CD95 (APO-1/Fas) cell surface receptors induces death in apoptosis-sensitive cells. Induction of apoptosis in adherent gamma interferonstimulated HT-29 and COLO 205 colon carcinoma cells by cross-linking CD95 with anti-APO-1 monoclonal antibody resulted in detachment of the cells from hyaluronate starting about i h after antibody exposure. Loss of adhesion was paralleled by a substantial reduction of the multifunctional cell surface adhesion molecule CD44. As evidenced by cycloheximide treatment, this effect was not caused by impaired protein synthesis. Depletion of surface CD44 was also not due to membrane blebbing, since cytochalasin B failed to inhibit ascension from hyaluronate. Instead, ELISA and time kinetics showed increasing amounts of soluble CD44 in the supernatant of CD95-triggered cells. SDS-PAGE revealed that soluble CD44 had an apparent molecular mass of about 20 kD less than CD44 immunoprecipitated from intact cells. Thus, CD95-triggering induced shedding of CD44. Shedding is a novel mechanism operative in early steps of CD95-mediated apoptosis. Shedding surface molecules like CD44 might contribute to the active disintegration of dying epithelial cells in vivo.
PoPVos]s is an irreversible intracellular program induced by a variety of internal and external stimuli and which leads to the cell's extinction. Apoptosis does not cause any tissue reaction except phagocytosis (Cohen and Duke, 1992 ). An early feature of cells undergoing apoptosis in tissues is detachment from neighboring cells or the basement membrane (Searle et al., 1982) . This also applies to colonic epithelium where senescent enterocytes undergo apoptosis, detach from the basement membrane, and are released into the gut lumen (Gavrieli et al., 1992; Str~iter et al., 1995) . There is good evidence that this phenomenon is maintained in colonic carcinoma cell lines in vitro. Induction of apoptosis in HT-29 cells by factors like transforming growth factor [3, etoposide, or teniposide leads to detachment from the substratum, and cells are found in the supernatant (Oberhammer et al., 1993; Desjardins and MacManus, 1995) .
CD95 (APO-1/Fas) is a 48-kD cysteine-rich type I transmembrane glycoprotein and is a member of the tumor necrosis factor receptor family (Itoh et al., 1991; Oehm et al., 1992) . Upon cross-linking of CD95 by antibody (Trauth et al., 1989; Dhein et al., 1992) or by its natural ligand, CD95-positive cells undergo apoptosis, provided the cells are sensitive. It has been shown that CD95 is expressed at high levels on colonic epithelial cells along the crypt axis and at the mucosal surface (M611er et al., 1994) . CD95 is often down-modulated in colon carcinoma in situ and on colon carcinoma cell lines (MOller et al., 1994) . Stimulation of cells by gamma interferon (IFN-~), 1 however, increases CD95-expression (MOller et al., 1994) and sensitizes cells for CD95-induced cell death (Yonehara et al., 1989) .
CD95 ligand is a 40-kD type II membrane protein belonging to the tumor necrosis factor family of cytokines (Suda et al., 1993; Smith et al, 1994; Takahashi et al., 1994) . Like other members of this cytokine family, CD95 ligand exists in a membrane-bound and soluble form (Dhein et al., 1995) . CD95 ligand in its biologically active form is a trimer (Nagata and Golstein, 1995) .
CD44 is a type I transmembrane glycoprotein involved in homo-and heterotypic cell adhesion and cell-matrix interaction. The CD44 core protein of 37 kD is N and O-glycosylated to an 85-95-kD form, the so-called standard (CD44s) or hematopoietic form or, by linkage of chon-droitin sulfate, to a 180-220-kD form (Goldstein et al., 1989; Jalkanen et al., 1989; Stameneovic et al., 1989 ). An intermediate-size form of 110-160 kD shows similar glycosaminoglycan substitutions as the hematopoietic form of CD44 and is primarily expressed on epithelial cells (Brown et al., 1991; Stamencovic et al., 1991) . Further structural complexity of the CD44 molecule comes from alternative splicing of at least 10 exons of the CD44 gene, giving rise to the so-called CD44 variants with altered adhesion properties (Gtinthert, 1993) . CD44 molecules act as receptors for fibronectin (Jaikanen and Jalkanen, 1992) , type I and IV collagen (Carter and Wayner, 1988) , and sulphated proteoglycan (Toyama-Sorimachi and Miyasaka, 1994) . The most selective CD44 ligand, however, is hyaluronate (Stamencovic et al., 1989) .
To investigate detachment of cells upon induction of apoptosis, we used HT-29 and COLO 205 colon carcinoma cell lines as models for epithelial cells. We show here that one of the early phenomenon of CD95-induced apoptosis is the loss of surface CD44 by proteolytic cleavage. This loss of CD44 abrogates the hyaluronate-binding capacity and therefore contributes to the early detachment of adherent cells seen during CD95-induced cell death 
Material and Methods
Reagents 3,4-dichloroisocoumarin (CDI), 1,10-phenanthroline, Na-p-tosyl-L-lysine chloro-methyl ketone (TLCK), cytochalasin B,
Cell Culture Conditions
Human colon carcinoma cell lines HT-29 and COLO 205 were purchased from American Type Culture Collection (Rockville, MD). Cells were kept in RPMI 1640 (GIBCO, BRL, Gaithersburg, MD) containing 10% fetal calf serum (FCS; PAA, Linz, Austria), 5 mM L-glutamine, 100 U/ml penicillin, and 100 ixg/ml streptomycin at 37°C, 5% CO2-atmosphere and were cultured on either plastic or hyaluronate. Culture plates were coated with hyaluronate (5 mg/ml) by incubating plates overnight at 4°C. Finally, precoated plates were blocked with BSA and cells were added. To sensitize cells to CD95-triggered apoptosis, HT-29 and COLO 205 were treated with 100 U/ml IFN-3, for 72 h (MOiler et al., 1994) . Apoptosis was induced by cross-linking surface CD95 with 500 ng/ml anti-APO-1 (Dhein et al.. 1992) . To remove adherent cells from culture plates, cells were incubated with trypsin/EDTA (Biochrom-KG, Berlin, Germany) for 5 min at 37°C. Subsequently, cells were washed twice with either RPMI or Hank's salt solution.
DNA Fragmentation Assay
For DNA fragmentation analysis, a pellet of 106 cells was lysed in 20 p.l lysis buffer (0.5% N-lauroylsarcosine, Sigma Chemical Co.; 10 mM EDTA; 50 mM Tris, pH 8.0; 0.5 mg/ml proteinase K) for 1 h at 50°C. After addition of 5pA of RNAse (1 mg/ml) and further incubation of 1 h at 50°C, lysates were electrophoresed in a 2% agarose gel containing ethidium bromide and photographed under UV illumination. Characterization of high molecular weight (HMW)-DNA damage was achieved by subjecting samples of sarcosyl-lysates (1% N-lauroylsarcosine, Tris-buffer, 2mg/ml proteinase K, pH 8.0) to pulse field gel electropboresis on 1% agarose gels The separated fragments were stained with ethidium bromide and photographed under a transilluminator. DNA fragments were compared to a lambda DNA ladder
Immunocytochemistry
Acetone-fixed cytospin preparations of cells were incubated for I h with primary monoclonal antibodies at appropriate dilutions. A biotinylated anti-mouse antibody, streptavidin/biotin-peroxidase (Amersham Corp., Buckinghamshire, UK), and aminoethyl-carbazole (Sigma Chemical Co.) served as a detection system for the primary antibody resulting in an intense red precipitate. After counterstaining with Harris ~ hematoxylin. slides were mounted with glycerol gelatine.
Flow Cytometry
We used several methods to analyze antigen expression, DNA content, or both in parallel. The first procedure was to resuspend 10 ~ cells in 50 ~l Hank's salt solution containing 0.1% sodium azide, 1.5% Hepes, and 2°/,, FCS. 50 ~l of diluted primary antibody was added and incubated on ice for 1 h. After washing, FITC-conjugated goat anti-mouse lgG at appropriate dilution was added. The cell suspension was incubated on ice for 1 h. Cells were washed in Hank's salt solution and immediately analyzed by flow cytometry on a FACScan © (Becton Dickinson lmmunocytometry Sys., Mountain View, CA) using LYSYS I1 software. To quantify cells with advanced DNA degradation, we used a procedure similar to that described by Nicoletti et al. (1991) . A pellet containing 1 × 106 cells was gently resuspended in 500 I~1 hypotonic fluorochrome solution containing 0.1% Triton X-100 (Sigma Chemical Co.), 0.1% sodium-citrate, and 50 p~g/ml PI. The cell suspensions were placed at 4°C in the dark overnight before flow cytometry analysis of cellular DNA content. To compare the immune phenotype of apoptotic and nonapototic cells, cells were immunostained with antibodies as described above. Subsequently, cells were washed with Hank's salt solution and then fixed m 2 ml ice-cold ethanol and incubated on ice for 1 h. After washing, cells were resuspended in 250 pA staining solution containing PI (80 iJ.g/ml) and RNAse (0.4 ~g/ml) in PBS. Cells were kept in the dark at room temperature for 15 rain and then incubated at 4°C overnight before analysis.
Enzyme-linked Immunosorbant Assay (ELISA)
Soluble CD44 in the culture supernatant was quantified using a soluble CD44s ELISA kit (Bender MedSystem, Vienna, Austria) containing CD44s (SFF-2) [lgG1 isotype] and polyclonal anti-mouse lgG1 as detection system. Samples were measured at 450 and 620 nm reference wavelength, respectively.
Pulse-chase Labeling of Cells, Incubation with Monoclonal Antibodies In Situ, Immunoprecipitation, and Enzymatic Treatment of Precipitates
HT-29 cells preincubated with 100 U/ml IFN-~/for 3 d were biosynthetically labeled with a mixture of [35S]methionine and -cysteine. To this end. two tissue culture flasks (75-cm 2 growth area) containing a semiconfluent cell layer were washed twice with RPMI 1640 medium without methionine and cysteine (ICN Flow Laboratories, Kelkheim, Germany). Adherent cells were incubated with 10 ml RPMI 1640 medium without metionine and cysteine and supplemented with 5% dialyzed FCS and 2 mM glutamine for 1 h at 37°C, to which subsequently 2 mCi [35S]methionine and [35S]cysteine solution (Promix, specific activity >1000 Ci/mmol, Amcrsham-Buchler, Braunschweig, Germany) was added. After a labeling period of 1 h at 37°C, the supernatant was washed off and cells were chased in complete RPMI 1640 medium containing lif0 U/ml IFN-~ for 16 h at 37°C. After washing with complete medium, cells in one flask were treated in situ with 3 ml anti-APO-1 monoclona/ antibody (500 ng/ml), whereas cells in the control flask were subjected to the same amount of CD30(Ki-!) monoelonal antibody, which served as an isotype-matched !ow control. Supernatants were harvested and centrifuged for 30 rain at i 2.000 g befole further processing. Cells of both flasks were washed twice with PBS and detached by means of 0.25% EDTA. Supernatants were precleared for immunoprecipitation by two nonspecific precipitations using protein A-Sepharose CL-4B (50% saturation: Pharmacia Fine Chemi-,;ais, lJppsaia, Sweden). Cells were solubilized in lysis buffer containing U!~:~ Nonidet P-40 and proteinase inhibitors (10 mM PMSF and 20 mU/ml aorotinin, both from Sigma Chemical Co.). Insoluble material was re~noved by ceutrifugation at 12000 g for 31) rain. The cell lysate containing supernatant was precleared by three sequential cycles of nonspecifie pre-~;ipitatlon using affinity-purified polycloual mouse IgG at 15 p~g/500/xl ly~ate together with 100 ~li5f)0 ~,1 lysate protein A-Sepharose CL-4B. For :~p,~cific immunoprecipitation, samples either from the supernatant or ~com the ceil lys~ate were mixed with t0 Izg of purified monoclonal anti-!~ody and 20 ~1 protein A-Seplaarose CL-4B. After overnight incubation ~t ,~,'~C with gentle rotation, the adsorbent was washed extensively and ,~hen boiled in reducing SDS .;ample buffer. Samples were subjected to ?AGE emptoymg a discontinuous buffer system. Gels were enhanced by treatment with DMSOtPPO and fluorographed on Kodak X-OMAT AR tilm (Rociaester. NY). To remove N-linked sugar moieties from the precipitated molecules, the washed adsorbents were resuspended in 100 mM Tris/HCl, pH 8,0, containing 0,5% SDS, 1% 2-mereaptoethanol. and 10 mM EDTA, and then were boiled and centrifuged. The supernatants were incubated with 0.5 U/sample endoglycostdase F/N-glycosidase F (Boehrmger-Mannheim Gmbtt) for 3 h at 37°( ". Subsequently, treated immunoprecipitates were reconstituted with threefold-concentrated reducing samizie buffer and run on SDS-PAGE.
Results "~ss of Adhesion Is an Early Event in CD95-mediated Apoptosis
HT-2q and C O L d 205 cells were grown as monotayers on plastic and on hyaluronate precoated surfaces. 24 h after treatment with UV irradiation (10 min), etoposide (100 IxM), or okadaic acid (10 nM), ceils showed morphological signs of apoptosis such as nuclear and cytoplasmatic condensation and, in the case of treatment with okadaic acid or UV irradiation, membrane blebbing. After about 24 h, most ceils featuring these morphological characteristics remained sessile. Although the surface membrane was still intact (as evidenced by PI exclusion), D N A fragmentation was in an advanced stage (see Fig. 4 ). Ascension of the cells into the supernatant started between 24 and 36 h and was significant after about 40 h. This observation was in fine with previous experiments on HT-29 cells in which the topoisomerase II inhibitor teniposide caused loss of adhesion, which was definitely preceded by internucleosomal DNA cleavage, as a very late event in drug-induced apoptosis (Desjardins et al., 1995) .
In contrast, after induction of apoptosis by anti-APO-l, the first alteration that was microscopically visible was the detachment of an increasing number of cells beginning at about 1 h after antibody administration. After 3 h of antibody treatment, adherent cells and cells in suspension were harvested and analyzed separately for morphology and D N A fragmentation. In cytospin preparations, a major subset of detached cells showed morphological criteria of apoptosis whereas sessile cells were essentially intact (data not shown). Hypodiploid D N A content was only observed in floating cells and not in adherent cells (Fig. 1) . The experiment was repeated with cells grown on uncoated plastic and yielded comparable results. 
CD95-mediated Ascension from Hyaluronate Is Due to Early Depletion of Surface CD44
1"o investigate whether CD95-mediated loss of adhesion was due to changes in the adhesion receptor profile of the cells, expression of surface molecules was examined by immunocytochemistry and flow cytometry. In fact, HT-29 and C O L d 205 cells exhibited a significant decrease in surface levels of a comprehensive panel of adhesion molecules. However, the early and extensive depletion of surface CD44 was most impressive (Fig. 2) . For further specification, floating and adherent cells were measured separately. While sessile cells still expressed CD44, cells in the supernatant were almost completely devoid of surface CD44. Many of these CD44-negative cells did not yet exhibit cytoptasmatic or nuclear condensation (data not shown). Pretreatment with cytochalasin B, a drug which disrupts microfilaments and interferes with the formation of apoptotic bodies (Cotter et al., 1992) , failed to decrease the anti-APO-l induced depletion of CD44 (data not shown) in contrast to integrin-type adhesion receptors (yon Reyher, U., J. StrOller, T. Barth, A.R. Gtinthert, K. Koretz, G. Moldenhauer, P.H. Krammer, and P. M611er, manuscript submitted for publication). Consistently, cells grown on hyaluronic acid were still ascending into the supernatant by similar treatment with anti-APO-1 and cytochalasin B (data not shown) while detachment was extensively delayed when grown on plastic or collagen (v. Reyher et al., submitted).
Kinetics revealed that CD95-mediated decrease of CD44 clearly preceded advanced D N A fragmentation (Fig. 3) ; ! h treatment of HT-29 cells with anti-APO-I led to a significant depletion of surface CD44, while no loss of DNA was detected by flow cytometry. After 2 h, about 90% of cells were CD44-negative and an hypodiploid DNA content was detected in about 25%. Only 3 h after antibody administration, nearly all nuclei exhibited DNA fragmentation.
In comparison, after inducing apoptosis in HT-29 cells with either UV irradiation, okadaic acid, or etoposide, CD44 depletion was only significant in UV-exposed cells. In this case, the decrease started after about 18 h and was preceded by DNA breakdown. Okadaic acid and etoposide failed to induce significant reduction of CD44 surface expression during the first 36 h, although most cells showed advanced D N A fragmentation and nuclear con- (Fig. 4) . These data collectively suggest that ascension of epithelial cells from hyaluronate caused by extensive depletion of surface CD44 may be specific for CD95-mediated apoptosis. 
It is generally accepted that H M W -D N

Depletion of Surface CD44 Is Not Due to Impaired Protein Synthesis
To determine whether the decrease/loss of CD44 was due to lack of synthesis and expression of new surface molecules, we inhibited protein synthesis of HT-29 cells using cycloheximide (5 ixg/ml). By measuring the decline of surface CD44 levels after cycloheximide treatment, the halflife of CD44 on HT-29 cells was determined to be about 12 h (data not shown). This is in keeping with published data of the kinetics of CD44 surface expression as determined by pulse chase experiments in T-lymphoma cells indicating a half-life of CD44 molecules is in the order of magnitude of 8 h (Lokeshwar et al., 1991 . Thus, the very different kinetics by which CD44 is lost from the cell surface after anti-APO-1 treatment are indicative for an active process.
CD95-triggering Induces Soluble CD44
CD44 is one of several surface molecules that can be shed by enzymatic cleavage. This was shown by cross-linking of CD44 (Bazil and Horejsi, 1992) and in phorbolester-stimulated leukocytes (Bazil and Strominger, 1994) . To clarify whether shedding is operative in anti-APO-l-triggered cells, supernatants were filtered using a 0.2-txm millipore filter before analysis. In supernatants of untreated cultures of HT-29 and C O L O 25 cells, levels of soluble CD44 were regularly low. After administration of anti-APO-1, levels of CD44 increased rapidly during the first 2 h (Fig. 6 ). These kinetics are in good accordance with the decrease of surface CD44 (Fig. 4) .
Cleaved CD44 Is Released into the Supernatant of CD95-stimulated HT-29 Cells
HT-29 cells induced by IFN--y and pulse chase labeled with [35S]methione and -cysteine were incubated in situ for 3 h at 37°C with either CD95(anti-APO-1) or CD30(Ki-1) isotype-matched control antibody. Supernatants of treated cells were immunoprecipitated with CD44(F10-44-2) (Fig. 7) . 
Protease Inhibitors Fail to Block Shedding of Su~ace CD44 Without Critically Interfering with the Apoptotic ,Signal Cascade
To determine the type of enzymes responsible for anti-APO-l-induced cleavage of surface CD44, several protease inhibitors were used at standard effective concentrations (Beynon and Salvesen, 1989) . In IFN-~, pretreated HT-29 and C O L d 205 cells, CD95-triggered detachment and shedding of CD44 were completely blocked by the serine protease inhibitor DCI (250 ~LM). However, at the same time, DCI inhibited DNA fragmentation as well as the occurrence of the typical morphology of apoptosis. This is in line with previous reports demonstrating that CD95-induced apoptosis is completely blocked by DCI (Los et al., 1995; Weis et al, 19951) . TLCK (200)~g/m[), a serine and leupeptin (100 ixg/ml), and a serine/cystein-protease inhibitor affected neither CD95-induced apoptosis nor apoptosis-associated loss of CD44. The metalloprotease inhibitors 1,10-phenanthroline (5 raM) or E D T A (5 mM), slightly delayed DNA fragmentation but did not influence CD95-induced shedding of CD44 melecules. Likewise, Boc-Asp(OBzl)-CMK (50 ixM), which is a specific interleukin-ll3 converting enzyme (ICE) inhibitor (Boudreau et al., 1995) , completely blocked CD95-triggered apoptosis. Taken together, the protease responsible for shedding of CD44 could not be positively characterized since the agents known to block shedding CD44 very basolateral surfaces, cell-cell and cell-matrix interactions take place that are mediated by different types of adhesion molecules. The interaction with the mlcroenvironmenl has a fundamental influence on cytoskeletal organization (Luna and Hitt, 1992) and gene regulation o[ the cells. Disruption of epithelial cell-matrix (Meredith et al., 1993; Frisch and Francis, 1994 ) and cell-cell interactions (Bates et al., 1994) was demonstrated to eventually cause apoptosis. This route to death, recently termed "anoikis" (Frisch and Francis, 1994) , may be crucial in preventing seeding of detached epithelia and endothelia at other sites. The present paper provides data suggesting that a functional link between loss of adhesion and apoptosis may be operative in both directions. We show that triggering CD95 on epithelial cells leads to loss of adhesion at early steps of programmed cell death. Such a mechanism may be advantageous for homeostasis of an organism since getting rid of apoptotic epithelia by extrusion, e.g., into a lumen, may diminish local phagocytic activity and thus stabilize the function of epithelia as a barrien It is well known that adherent cells in vitro can be readily removed from the substratum when subjected to limited proteolysis. It has been speculated that this might in fact be the mechanism by which cells detach from adjacent structures during apoptosis (Martin and Green, 1995) . We show here that the multifunctional adhesion molecule CD44 is proteolytically shed from the cell surface early during CD95-induced cell death. These data, therefore, support the above assumption.
The question arises, which protease is responsible for the CD95-mediated shedding of CD44? CD44 was reported to be proteolytically cleaved from the cell surface of phorbolester-stimulated leukocytes (Bazil and Strominger, 1994) and upon cross-linking by specific antibodies (Bazil and Horejsi. 1992) . Phorbolester-induced CD44 shedding was inhibited by 1,10-phenanthroline, EDTA, and DCI. hence by inhibition of metalloproteases and serine proteases, respectively. To investigate whether such proteases also account for CD95-induced cleavage of CD44, we applied a similar panel of protease inhibitors as they were used in these studies. In our system, however, the cation chelators 1A0-phenanthroline and EDTA, as previously reported (Schulze-Osthoff, 1994) , reduced the response Io anti-APO-1 treatment but had no influence on CD44 shedding from apoptotic cells. Thus, it is highly unlikely that phorbol ester-induced metalloproteases are involved in this mechanism. On the other hand, DCI prevented detachment of cells and loss of surface CD44. This, however, turned out to be due to blocking of the apoptotic program per se. It has been shown that DCI prevent CD95-induced cell death in SKW6.4 (Los et al., 1995) and Jurkat cells (Wets et al., 1995) , possibly by inhibition of ICE (Los et al., 1995) , which is a cystein-protease. ICE is a member of the family of ced-3-1ike proteases promoting apoptosis (for review see Martin and Green, 1995) . Specifically blocking ICE by Boc-Asp(OBzl)-CMK had the published effect (Boudreau et al., 1995) in preventing apoptosis. In critical conclusion, the membrane-bound protease responsible for CD95-induced shedding of CD44 is as yet undefined.
Studies of Williams and Henkart (1994) have demonstrated that injection of several proteases, including a serine protease, proteinase K, into the cytoplasm of cells results in apoptosis within a few hours. Interestingly, treating HT-29 cells with extra-cellular proteinase K gave rise It) a very selective loss of surface CD44 in the same order of magnitude and with kinetics as seen during CD95-induced apoptosis (own unpublished observations) Shedding of surlace CD44 is likely to be an importan! factor in the death program since it contributes to loss of cell-cell and cell-matrix anchorage and, in addition, might cut off survival-sustaining signals (Shimizu et al., 1989 : Galandrini et al., 1993 Ayroldi et al., 1995) .
